<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="78869">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01782846</url>
  </required_header>
  <id_info>
    <org_study_id>2010/45</org_study_id>
    <nct_id>NCT01782846</nct_id>
  </id_info>
  <brief_title>Trama-Code (Two Analgesics-comparative Study)</brief_title>
  <acronym>Trama-Code</acronym>
  <official_title>Double Blind-randomized Study Comparing the Efficacy of Two Analgesia (Ixprim® and Dafalgan-Codeine®) , in the Emergency Unit.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double-blind randomized study to compare the efficacy of two analgesic drugs(Ixprim®,
      Dafalgan-Codeine®) in the emergency unit.

      The efficacy (relief of pain) would be assessed 2 hours after administration of one of the
      two drugs in a patient presented to the emergency unit with a moderate pain (4 to 6 on pain
      assessment score).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study</study_design>
  <primary_outcome>
    <measure>pain improvement</measure>
    <time_frame>120 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ixprim®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 capsules of Ixprim® given orally (1000 mg Paracetamol + 75 mg Tramadol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dafalgan Codeine®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two capsules of Dafalgan Codeine® given orally (1000 mg Paracetamol + 46.8 mg Codeine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ixprim®</intervention_name>
    <arm_group_label>Ixprim®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dafalgan-Codeine®</intervention_name>
    <arm_group_label>Dafalgan Codeine®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of 18 - 75 years of age

          -  Presented to the emergency unit of FOCH hospital

          -  Complaining of moderate pain (4-6 on pain assessment scale) evaluated by the
             reception nurse

        Exclusion Criteria:

          -  Patient already had received another type 2 analgesia or already received one of the
             study drugs in the last 4 hours

          -  pregnant or lactating females

          -  Patient with one or more contraindication to one of the study drugs

          -  Patients for whom the pain assessment scale can not be performed (unconscious,
             confused ...)

          -  Patient cannot be included for legal reasons

          -  Patient required urgent management

          -  Patient for whom it is considered difficult to be reassessed 2 hours later

          -  Patient unable to swallow
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emmanuel Mathieu, MD</last_name>
    <phone>+33 1 46252028</phone>
    <email>e.mathieu@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital FOCH - Emergency unit</name>
      <address>
        <city>Suresnes</city>
        <state>Ile de France</state>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Mathieu, MD</last_name>
      <email>e.mathieu@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 31, 2013</lastchanged_date>
  <firstreceived_date>January 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
